In most vertebrates, the upper digestive tract is composed of muscularised jaws linked to the esophagus that permit food uptake and swallowing. Masticatory and esophagus striated muscles (ESM) share a common cardiopharyngeal mesoderm (CPM) origin, however ESM are unusual among striated muscles as they are established in the absence of a primary skeletal muscle scaffold. Using mouse chimeras, we show that the transcription factors Tbx1 and Isl1 are required cell-autonomously for myogenic specification of ESM progenitors. Further, genetic loss-of-function and pharmacological studies point to Met/HGF signalling for antero-posterior migration of esophagus muscle progenitors, where HGF ligand is expressed in adjacent smooth muscle cells. These observations highlight the functional relevance of a smooth and striated muscle progenitor dialogue for ESM patterning. Our findings establish a Tbx1-Isl1-Met genetic hierarchy that uniquely regulate esophagus myogenesis and identify distinct genetic signatures that can be used as a framework to interpret pathologies arising within CPM derivatives.
INTRODUCTION
Evolution of vertebrates has been marked by the emergence of muscularised jaws that transitioned them from filter feeders to active predators (Northcutt, 2005) . Considerable diversity in developmental origins and regulation of skeletal muscles point to important functional differences that remain unexplored. Muscles of the trunk originate from the segmented somites, whereas head muscles arise independently, from the non-segmented cranial paraxial mesoderm located anterior to the somites (review Diogo & Sambasivan) . The specification of head and trunk muscles involves divergent genetic regulatory networks, to activate bHLH myogenic regulatory factors (MRFs) Myf5, Mrf4, Myod and Myogenin that play crucial roles in governing striated muscle cell fate and differentiation Kassar-Duchossoy et al., 2005; Rudnicki et al., 1993) .
While somitic myogenic progenitors are regulated primarily by the paired/homeodomain genes Pax3 and Pax7 and Myf5 that act genetically upstream of Myod (Kassar-Duchossoy et al., 2005; Relaix et al., 2005; Tajbakhsh et al., 1997) , cardiopharyngeal mesoderm (CPM) progenitors, that colonize pharyngeal arches and form craniofacial and neck muscles, are regulated by a Pax3-independent regulatory network (Diogo et al., 2015; Sambasivan et al., 2011) . CPM progenitors specified by Tbx1 and Isl1 genes are bipotent as they form branchiomeric subsets of head/neck muscles as well as the second heart field (Diogo et al., 2015; Kelly et al., 2004; Lescroart et al., 2015; Sambasivan et al., 2009) . Tbx1 acts together with Myf5 to assure myogenic fate (Harel et al., 2009; Kelly et al., 2004; Nathan et al., 2008; Sambasivan et al., 2009 ). In Tbx1-null embryos, the first pharyngeal arch is hypoplastic and posterior pharyngeal arches do not form, resulting in variably penetrant defects of masticatory muscles and absence of muscles derived from more posterior arches including those of the larynx and esophagus (Gopalakrishnan et al., 2015; Heude et al., 2018; Kelly et al., 2004; Lescroart et al., 2015) .!Tbx1 exerts cell-autonomous and non-autonomous roles as conditional deletion of Tbx1 in CPM and pharyngeal endoderm phenocopies the pharyngeal arch and cardiac outflow tract phenotype of the null mutant (Arnold et al., 2006; Kelly et al., 2004; Zhang et al., 2006) . On the other hand, the functional role of Isl1 in CPM specification remains unknown due to early embryonic lethality of Isl1-null mutants (by E10.5) that exhibit cardiac deficiencies (Cai et al., 2003; Harel et al., 2009; Nathan et al., 2008) . Thus, due to the severe phenotypes observed in the mouse, the epistatic relationship between Tbx1 and Isl1 and their cell-autonomous roles during ESM formation remain unclear .
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Recent studies by us and others showed that CPM progenitors generate diverse myogenic subpopulations at the transition zone between head and trunk (Diogo et al., 2015; Gopalakrishnan et al., 2015; Heude et al., 2018; Schubert et al., 2018; Tabler et al., 2017) .
Whether CPM muscle derivatives form a homogeneous group specified by a unique gene regulatory network is unknown. Esophagus striated muscles (ESM) arise from CPM and they exhibit several features that are distinct from other striated muscles in the organism. Notably, ESM formation initiates in the foetus, thus embryonic myogenesis which generates primary myofibres that act as scaffolds for secondary (foetal) myofibres does not take place. As the esophagus is the only site identified to date that undergoes this unusual patterning, this raises the issue of what cell type (s) pattern ESM.
The esophageal muscularis externa comprises a variable amount of striated muscle (Krauss et al., 2016) ,which has a distinct developmental origin than the smooth muscle layer (Gopalakrishnan et al., 2015; Rishniw et al., 2003; Zhao and Dhoot, 2000) . Interestingly, birds and reptiles lack the striated muscle component in the esophagus suggesting that mastication and processing of bolus through the digestive tract might have common evolutionary links (Gopalakrishnan et al., 2015) . In ESM-containing species, postnatal maturation of the esophageal musculature involves proximo-distal replacement of smooth muscle by as yet elusive mechanisms (Krauss et al., 2016) . Although smooth muscle and other mesenchymal cells are in close proximity to ESM progenitors as they undergo lineage commitment and differentiation, how the latter are patterned in the absence of primary myofibres remains unknown. It has been proposed that smooth muscle may provide a scaffold for laying down ESM myofibers, however it is unclear to what extent this differs from other sites in the organism where striated muscles play this role (Gopalakrishnan et al., 2015; Zhao and Dhoot, 2000) .
Perturbations of esophagus function leads to dysphagia and other physiopathological disorders that impair swallowing and transfer of bolus to the stomach (Sheehan, 2008) . ESM share a common origin with branchiomeric head muscles (Gopalakrishnan et al., 2015; Heude et al., 2018) and like those muscles, Tbx1 and Isl1 act as upstream regulators of ESM development (Gopalakrishnan et al., 2015) . In Tbx1-null embryos, Isl1-derived myogenic cells fail to seed the anterior esophagus, suggesting that Tbx1 acts genetically upstream of Isl1 in ESM progenitors (Gopalakrishnan et al., 2015) . Initially, CPM-derived progenitors are seeded at the bottom of the oropharyngeal cavity by E13.5. Then, Isl1-derived ESM progenitors colonize the esophagus by migration and differentiation until the third week of perinatal growth ! 5! (Gopalakrishnan et al., 2015; Romer et al., 2013) . How these Isl1 progenitors colonize the structure while restricting premature differentiation remains unknown.
Muscle progenitors undergo short-range displacement or long-range migration for establishing skeletal muscles, as exemplified by myotomes and limbs, respectively. Progenitors originating from ventral somites delaminate and emigrate to distal sites to give rise to trunk, limb and tongue muscles Brand-Saberi et al., 1996; Dietrich et al., 1999) . This process is regulated by the tyrosine kinase receptor Met, expressed in migratory progenitors, and its ligand Scatter Factor/Hepatocyte Growth Factor (SF/HGF) expressed in mesenchymal cells along the migratory route Brand-Saberi et al., 1996; Dietrich et al., 1999) . Knockout of either Met or Hgf in mice results in the absence of hypaxial muscles including limb muscles, diaphragm and the tip of the tongue Dietrich et al., 1999; Maina et al., 1996; Prunotto et al., 2004) . Although second (hyoid) arch-derived muscles are affected in Met KO mice (Prunotto et al., 2004) , a role for Met/HGF in establishing other CPM muscles including those in the larynx and esophagus has not been reported.
In the present study, we used mouse chimeras to circumvent lethality issues and assessed the cell-autonomous roles of Tbx1 and Isl1 in ESM progenitors. Using genetic loss-of-function and pharmacological inhibition approaches, we show that Met/HGF is critical for ESM patterning, but not for the establishment of adjacent laryngeal muscles. These studies unveil an unexpected Tbx1/Isl1/Met genetic hierarchy operating within a CPM-muscle group, thereby identifying distinct genetic signatures for these evolutionarily conserved mesodermal derivatives.
RESULTS

Requirement of Tbx1 and Isl1 in ESM specification
We showed previously that Tbx1-null embryos lack ESM, wherein Isl1-derived myogenic progenitors fail to colonise and pattern the esophagus (Gopalakrishnan et al., 2015) . The absence of seeding of Isl1-derived ESM progenitors in the anterior esophagus of Tbx1-null mice could originate from cell-autonomous or non-autonomous defects. To distinguish between these possibilities, we generated two types of chimeric embryos to explore the epistatic relationship between Tbx1 and Isl1 during ESM formation. Embryonic chimeras are wellestablished tools that have provided key insights into the tissue-specific requirement of genes during mammalian development (Tam and Rossant, 2003) .
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We first generated chimeras by injection of Isl1 lacZ (KI) ES cells (Sun et al., 2007) in Tbx1 -/and control (Tbx1 +/-) blastocysts to determine if Tbx1/Isl1-positive cells can colonize the esophagus in a Tbx1 null environment. Here, !-galactosidase (!-gal) expression is under the control of the Isl1 promoter to trace the ES-derived cells in vivo ( Figure S1A,B ). All Tbx1-null chimeric embryos analyzed between E14.5 and E15.5 lacked thymus glands (9/9) and 77% of them (7/9) were edemic and lacked the outer ear pinna indicating that the injection of Isl1 lacZ ES cells (Tbx1 wildtype ) was not extensive enough to fully rescue the Tbx1 knockout phenotype (Figure S1C, D) . Analysis of embryos by whole mount X-gal staining showed that 5/5 chimeric Tbx1 -/embryos contained !-gal + cells in the esophagus ( Figure S1E ), though to variable extent in individual embryos when compared to heterozygous controls. Apart from its expression in ESM progenitors, Isl1 is expressed in peripheral neurons (Pfaff et al., 1996) and in the pharyngeal and esophageal epithelium (Cai et al., 2003; Harel et al., 2009; Nathan et al., 2008) .
Therefore, we performed an analysis on tissue sections to assess !-gal expression at the cellular level. We observed that !-gal+ cells were present within the smooth muscle layers of the esophagus of Tbx1-null embryos (8/8 chimeras), and colocalised within Tnnt3+/Tuj1-(myogenic/non-neurogenic) cells (Figure S1F,G). While ESM colonization in chimeric Tbx1 -/embryos appeared to be less efficient than in controls (determined by number of !-gal+ cells/section and Tnnt3+ muscle area/section), the relative number of !-gal+ cells/Tnnt3+ muscle area was non significantly altered (Figure S1H-J). Taken together, these data indicate that Isl1 lacZ ES cells can colonize an overall Tbx1-null esophageal environment suggesting cell autonomous potential of Tbx1+/Isl1+ progenitors to seed and pattern the ESM. Of note, cells expressing lower levels of !-gal were present in the esophagus epithelia and connective tissue layers of both control and chimeric Tbx1-null embryos suggesting that in these cells expression from the endogenous Isl1 locus was downregulated, and therefore the extent of the contribution of Isl1 lacZ ES cells (Tbx1 wildtype ) cannot be unambiguously assessed. To circumvent this issue, we generated a second series of chimeras to address the intrinsic role of Isl1 during foetal esophagus myogenesis.
To bypass the early embryonic lethality of Isl1-null embryos (Cai et al., 2003) , we generated chimeric foetuses by injection of Isl1-null ES cells into wildtype (WT) mouse blastocysts. We targeted Isl1-null and control (WT) ES cells with a constitutively expressing lacZ cassette (pCAG-nlacZ; nuclear !-gal activity) to trace ES cell derivatives ubiquitously and independently of Isl1 expression ( Figure 1A-B ). Macroscopic examination of chimeras at E16.5 ! 7! did not reveal obvious developmental defects in Isl1-null chimeras compared to controls.
Immunostainings on sections were then performed to evaluate the contribution of Isl1-null (ES:Isl1 -/-; nlacZ) and control (ES:WT; nlacZ) !-gal+ ES-derived cells to the esophagus myogenic population. For reference, contribution of !-gal+ ES-derived cells was compared with Isl1 lineage tracing (Isl1 Cre/+ ;R26 mT/mG/+ embryos), whereby GFP+ Isl1-derived CPM cells contribute to the esophagus myogenic population (Myod/Myog/Tnnt3+), but not to the esophagus smooth muscle (SMA+) and striated muscle of tongue that develop in an Isl1independent context ( Figure 1C -E). We then quantified the amount of chimerism and !-gal+ cells in the esophagus SMA+ and Myod/Myog+ populations and in myogenic cells of the tongue (n=3, Figure 1F -K). In both Isl1-null and control chimeras, the overall percentage of chimerism in the tongue was similar to that observed in the muscularized layers of the esophagus ( Figure 1L -M, left pannels). In the esophagus of control chimeras, !-gal+ gave rise to both SMA+ (31%-46%) and Myod/Myog+ populations (25%-43%) ( Figure 1F ,G,L). In contrast, Isl1-null/!-gal+ cells were excluded from the esophagus Myod/Myog+ cells ( Figure   1I ,J,L), whereas they contributed to a similar extent to esophagus smooth muscle and tongue myogenic cells in both Isl1-null and control chimeras. These results show that Isl1 is necessary cell-autonomously for progenitor cells to adopt a myogenic cell fate in the esophagus ( Figure   1B ).
Spatiotemporal activation of the ESM myogenic program
ESM development is biphasic, with initial seeding of Isl1-positive myogenic progenitors at the anterior esophagus followed by anterior-posterior migration and differentiation. To determine the expression of Isl1 relative to the commitment MRF genes during ESM patterning, we performed RT-qPCR analysis at key stages of ESM development: at E15.5 and E17.5 when one third and two thirds of the esophagus contain ESM progenitors, respectively; then at 3 weeks postnatally when the entire esophagus is muscularized. Isl1 and Myf5 were detected in the anterior, middle and posterior esophagus as ESM progenitors colonize the structure from E15.5 to 3 weeks postnatally (Figure 2A -C). Isl1 expression was also detected in the stomach, as already described for the gastric epithelium (Das and May, 2011) . We next performed RT-qPCR analysis for Isl1 in myogenic cells isolated from Tg:Pax7nGFP mice where Pax7+ progenitors can be isolated from mid-embryonic stages (Sambasivan et al., 2009) (Figure 2D ).
Isl1 was expressed in Pax7-nGFP + esophagus progenitors, whereas expression was low or undetectable in those isolated from the masseter at all stages analyzed. Therefore, Isl1 ! 8! expression is maintained in myogenic progenitors throughout ESM development.
We then asked what molecular pathways would guide ESM progenitors to undergo A-P migration. Given the key role for Met/HGF signalling during myogenic migration and cell proliferation Dietrich et al., 1999; Maina et al., 1996; Prunotto et al., 2004) , we performed RT-qPCR analysis for Met in Pax7nGFP + in the esophagus. Notably, ESM progenitors showed transcript abundance of Met at fetal stages and lower expression levels postnatally when ESM colonization was complete ( Figure 2E ) suggesting that Met/HGF signalling might be implicated in A-P migration of ESM progenitors.
Severe loss of ESM in Met and Hgf mutants
To address the role of Met/HGF signalling during ESM formation, we examined Met D/D and Hgf-null mutants (Maina et al., 1996; Schmidt et al., 1995) . We first analysed the esophagus phenotype of Met and Hgf mutants at E16.5 by immunostainings on tissue sections for early myogenic and myofiber markers (Myod/Myog/Tnnt3), for smooth muscle (SMA) and lumen epithelium (E-Cad) markers. Interestingly, Met D/D and Hgf-null foetuses showed absence of striated muscles in the esophagus, while the smooth muscle layers and lumen epithelium appeared unaffected ( Figure 2F Analysis on sections revealed that Isl1+ progenitors had seeded the anterior esophagus smooth muscle layers in mutant embryos similarly to controls at E13.5 ( Figure 3A Figure S3A ,B) and E17.5 ( Figure 3D ,E) showed that Myf5 + myogenic cells were also present in the anterior-most portion of the esophagus in the mutant, whereas in the controls, colonization had proceeded posteriorly. Of note, the neuronal and smooth muscle lineages appeared to be present and patterned in the mutant ( Figure 3D ,E).
Next, we investigated the fate of the sporadic myogenic cells remaining in the anterior esophagus of Met-null foetuses. To this end, we combined the Met D/D mutant with Isl1 lineage ! 9! tracing. Analysis of E14.5 and E17.5 Met D/+ ; Isl1 Cre/+ ;R26 mT/mG/+ control embryos showed that mGFP + mononucleated cells could be abundantly detected between myofibres ( Figure 3F , Figure S3C ). However, very few mononucleated mGFP+ cells were detected between the residual myofibers in the anterior-most part of the esophagus in the Met mutant ( Figure 3G ; Figure S3D ). Strikingly, the adjacent Isl1-derived laryngeal and pharyngeal muscles were unaffected in the Met-null foetuses ( Figure 3C ,C',D-G; Figure S3A -D). Therefore, these observations indicate that Met/HGF affect only a subset of posterior CPM-derived progenitors that are critical for colonisation of the esophagus but not for the development of adjacent Isl1lineage derived muscles.
Taken together, these results indicate that Met acts downstream of Isl1 in the molecular hierarchy of ESM formation and that Met/HGF signalling is not implicated in initial seeding of Isl1-derived progenitors at the anterior esophagus, but rather during the second phase of migration within this structure.
Requirement of Met/HGF signalling for A-P migration of ESM progenitors
We then wondered if the defect in ESM formation in Met mutants is due to an increase cell death or deficient migration of Isl1 + progenitors. We first tested if Isl1-derived ESM progenitors undergo apoptosis in the Met D early embryos. TUNEL analysis of E13.5 mutants showed that Isl1+ progenitors are not apoptotic ( Figure S4A ,A').
Next, we investigated the role of Met in the migration of mGFP+ cells in an ex vivo esophagus explant culture system once they had colonized the upper esophagus ( Figure 4A ). To this end, we employed static and time-lapse confocal microscopy in combination with two selective ATP-competitive inhibitors of Met, PF-0417903 and MGC-265 or DMSO as control, on E14.5 Isl1 Cre ;R26 mT/mG esophagus ( Figure 4B -D). On static cultures (followed up to 24h) and time lapse imaging (up to 14h), we observed a mGFP+ mononucleated cell front that remained throughout the entire length in control cultures ( Figure S4B , Figure 4B , Movie S1). In addition, time-lapse movies showed that mGFP+ cells explored the esophagus scaffold repeatedly changing their direction of migration, but had a net movement posteriorly towards the stomach ( Figure 4E , Movie S1). Upstream of the mononucleated cell front, mGFP+ cells also migrated posteriorly in between forming fibers (Movie S1). In contrast, upon addition of Met inhibitors, mGFP+ cells progressed less towards the posterior end ( Figure 4C Interestingly, mGFP+ fibers appeared rapidly in the inhibitor treated cultures in positions where the cell density appeared higher ( Figure 4C , D, Figure S4C ), a phenotype that resembled Metnull embryos ( Figure 4G , Figure S3D ). To confirm this, we examined the proliferation and differentiation status of ESM myogenic cells in vivo by EdU labelling. Analysis of E14.5 and E15.5 embryos showed that myogenic cells in Met D mutant embryos have a proliferation rate that is one third of controls (45,6% for Ctrl; 12,5% for Mutant at E14.5, Figure S4D ) and a higher predisposition to differentiation as assessed by Myogenin expression (33% for Ctrl; 66%
for Mutant at E14.5, Figure S4E ). In summary, our ex vivo and in vivo analysis support the notion that Met/HGF signalling is required for A-P migration of ESM progenitors once they have colonized the upper esophagus, and this effect is accompanied by an apparent precocious differentiation of Isl1-derived progenitors.
Single cell analysis of ESM progenitors defines relationships between Met and Isl1
We then decided to examine in detail the expression pattern of Hgf and Met in relation to Isl1derived progenitors. Owing to the limited diffusion efficiency of HGF in vivo, both receptor and ligand expressing cells are expected to be found in close proximity to each other (Dietrich et al., 1999) . In situ hybridization (Rnascope®) on E14.5 Isl1 Cre ;R26 mT/mG embryo cryosections, revealed that Hgf is expressed adjacent to mGFP+ cells in a bilayered concentric pattern corresponding to the smooth muscle layers of the esophagus ( Figure 5A,B ). As expected, Met was expressed at high levels in Isl1-derived mGFP+ cells, and also in luminal epithelial cells ( Figure 5C ). However, the levels of Met transcript in mGFP+ cells were heterogeneous. Coimmunostaining with Myod and Myog antibodies to detect differentiating myogenic cells, revealed that 44% of mGFP+ cells were Myod+/Myog+ and that 80% of these Myod+/Myog+ cells had low levels of Met transcript (score 0/1; Figure 5C1 ,C2,D,E). Conversely, 90% of Myod-/Myog-cells, expressed high levels of Met (score 3/4) ( Figure 5C1 ,C2,E). Therefore, expression of Met was inversely correlated with the differentiation status of Isl1-derived cells.
To investigate the relative expression status of these myogenic markers in more detail, we performed single cell RT-qPCR analysis of Isl1-derived ESM progenitors. The mononucleated cell front in the esophagus of E15.5 Isl1 Cre ;R26 mT/mG mice was dissected and the expression of myogenic markers was examined in GFP+ isolated by fluorescence activated cell sorting (FACS) ( Figure S5A ). The normalized relative expression of the studied genes for all the ! 11! filtered cells that was annotated in a heatmap ( Figure S5B ) revealed two groups of genes. The first group included Isl1, Met, Pax7 and Myf5 which were detected in nearly all the single cells analysed. The second group included Mrf4, Myog and Myod1 which were expressed in a subset of cells. To assess the degree of relatedness between genes, we calculated the Spearman's correlation between all pairs of genes and noted that the expression of Isl1, Met, Pax7 and Myf5 was significantly positively correlated ( Figure 5F ). In contrast, Isl1 expression showed no significant correlation with the expression of more downstream MRF genes (Myod, Myog, and Mrf4 ). This indicates, that Isl1 is associated with the upstream state as expected, and that Isl1
and Met likely act concomittantly in myogenic progenitors during ESM formation.
DISCUSSION
In vertebrates, branchiomeric head and neck muscles share a common CPM progenitor pool regulated by upstream molecular players including Tbx1 and Isl1. Here, we uncover a cellautonomous requirement of Tbx1 and Isl1 in the specification of CPM-derived esophagus myogenic progenitors. In addition, we show for the first time a unique dependency of myogenic progenitors on Met/HGF signalling pathway for esophagus spatio-temporal patterning.
Surprisingly, laryngeal muscles that also originate from the posterior pharyngeal arches, are unaffected in Met mutants, thereby uncoupling the genetic requirements between ontogenically similar groups of CPM-derived muscles. These findings highlight distinct genetic hierarchies operating with CPM derivatives, and provide a framework to address myopathies of cranial origin ( Figure 6 ).
Cell-autonomous role of Isl1 during esophagus myogenesis
Recent genetic studies revealed that neck muscles including pharyngeal and laryngeal muscles, the trapezius and the esophagus originate from posterior pharyngeal arch mesoderm derived from an Isl1-lineage (Gopalakrishnan et al., 2015; Heude et al., 2018; Lescroart et al., 2015; Tabler et al., 2017) . We previously demonstrated that Tbx1 and Isl1 genes play key upstream roles during ESM formation (Gopalakrishnan et al., 2015) . In Tbx1-null embryos, Isl1-derived ESM fail to form, indicating that Tbx1 acts upstream of Isl1 during esophagus myogenesis (Gopalakrishnan et al., 2015) . Given that Isl1 promotes cell proliferation and represses myogenic differentiation, Isl1 has been proposed to exert a conserved role in the specification of CPM progenitors (Cai et al., 2003; Diogo et al., 2015; Harel et al., 2009 ). However, the intrinsic role of Isl1 in CPM derivatives has not been addressed due to early embryonic lethality (Cai et al., 2003) . Here, by means of chimeric analysis, we show that Isl1-null ES cells are ! 12! specifically excluded from the ESM indicating that Isl1 acts cell-autonomously during ESM formation at fetal stages, further supporting its role in the specification of branchiomeric myogenic progenitors.
Met/HGF signalling drives esophagus progenitor migration
During development, positional information that includes migration cues is often imparted to cells through intercellular signalling to allow proper spatio-temporal patterning. Several studies have uncovered the role Met receptor and its ligand HGF in the proliferation and motility of long-range myogenic progenitors (Trusolino et al., 2010) . The Met allele used here (Met D ) carries a mutation in two phosphotyrosines (Tyr1349, Tyr1356) in the carboxy-terminal tail, which completely abrogates Met function and recapitulates the Met null phenotype Maina et al., 1996; Maina et al., 2001) . Previous work showed that in Met and Hgf mutants, Pax3-derived hypaxial muscles are missing, while other trunk muscle groups appear unaffected Dietrich et al., 1999; Maina et al., 1996; Prunotto et al., 2004) .
Here, we show that ESM is also absent in both mutants. At early stages, Isl1+ progenitors seeded in the anteriormost part of the esophagus are not apoptotic in Met D/D mutants, suggesting that Met does not have a role in survival of premigratory myogenic cells. The first obvious deficiency observed in the Met D/D null is seen at the time Isl1+ progenitors colonize the smooth muscle scaffold (by E14.5). In the control, colonization progresses posteriorly, myofibers are formed while maintaining a pool of progenitor cells. In the mutant, only few Isl1-derived myofibers are present in the upper esophagus. ,Therefore Met has a role in motility as well as the balance between proliferation and differentiation of Isl1-derived myogenic cells once they have entered the smooth muscle scaffold.
A migration vs differentiation balance for esophagus myogenic progenitors
In the trunk, Hgf is first expressed adjacent to somites, and subsequently along the migratory route and at target sites in limb connective tissue (Dietrich et al., 1999) . In the esophagus, we identified the smooth muscle layer, which serves as a scaffold for myogenic progenitor migration, to be a major source of Hgf. This finding underscores the functional relevance of smooth and striated muscle progenitor interactions for proper ESM patterning that is unique compared to muscle patterning elsewhere. Hgf expression at the time of myogenic progenitor migration was observed throughout the length of the esophagus, suggesting that Met/HGF signalling is important all along the migration phase. It has been proposed that a prolonged ! 13! interaction between Met and Hgf may be required to prevent cell re-aggregation, thereby maintaining cell motility and prevent expression of the MRFs (Dietrich et al., 1999) . Whether motility prevents or delays expression of the differentiation genes or differentiation gene expression stop motility is unclear. However, it has been shown that precocious expression of MRFs in dermomyotomal muscle progenitors prevents their migration into limb buds (Bonnet et al., 2010) , while application of HGF results in reduction of Myod expression (Scaal et al., 1999) . and its paralogue Pax7 have partially redundant functions in muscle progenitors (Relaix et al., 2006) . Intringuingly, Pax7 mutant mice have impaired ESM formation due to reduced proliferation and precocious differentiation at the migratory front (Chihara et al., 2015) . Thus, it will be interesting to explore if Pax7 or Isl1 directly regulate Met expression in ESM.
Myogenic diversity within CPM-derived muscles
An unexpected finding from our work is that CPM muscles originating from posterior pharyngeal arches are differentially affected in Met mutants. Head muscles derived from the second pharyngeal arch and giving rise to branchiomeric facial muscles (orbicularis occuli, buccinator, platysma) appear either strongly reduced or absent, while first arch derived masticatory (masseter, temporalis) and extraocular muscles are present in Met D/D mutants (Prunotto et al., 2004) . However, we show that posterior branchiomeric neck muscles including pharyngeal and laryngeal muscles, are present in Met D/D mutants while adjacent ESM is absent.
Thus, we have established a unique Tbx1-Isl1-Met genetic hierarchy in ESM progenitors that is distinct from other posterior branchiomeric muscles ( Figure 6 ).
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The genetic regulatory pathways that give rise to functionally distinct groups of muscles has provided critical information to understand heterogeneity in response to genetic diseases, such as DiGeorge syndrome where mutations in TBX1 result in the impared function of subsets of the craniofacial and pharyngeal apparatus with varied degrees of severity. Understanding the functional dynamics of Tbx1 and Isl1 in specific muscles groups will help uncover differences between the ontogenically similar group of CPM derived muscles. Uncoupling the genetic requirements of these distinct populations is necessary to provide a framework that will explain how human myopathies affect only subsets of muscles (Emery, 2002; Randolph and Pavlath, 2015) .
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MATERIALS AND METHODS
Animals
Animals were handled as per European Community guidelines and the ethics committee of the Institut Pasteur (CTEA) approved protocols. Isl1 Cre (Srinivas et al., 2001) , reporter mouse lines R26R mT/mG (Muzumdar et al., 2007) , Myf5 nLacZ (Tajbakhsh et al., 1996) , Tg: Pax7nGFP (Sambasivan et al., 2009) , and mutant mice carrying the Tbx1 tm1pa allele (referred to as Tbx1 -/-) (Jerome and Papaioannou, 2001) , Hgf (Schmidt et al., 1995) and Met (referred as Met D ) (Maina et al., 1996) To trace the ES clones, CAG-nlacZ and PGK-puro cassettes were cloned into a pBluescript to produce a nlacZ reporter puromycin resistant plasmid. Heterozygous and homozygous Isl1null;nLacZ ES cells were electroporated (0.5-1 x 10 7 cells) with 20 µg of linearized pCAGnlacZ-puro plasmid by using a BTX Harward apparatus ECM830 electroporator with ! 16! one pulse at 240V for 15ms. Three days after transfection, positive clones were selected in ES derivation medium with puromycin (1.5µg/ml) for 5 days. ES colonies were picked into 24well plates and tested for expression of the nLacZ reporter (X-Gal/immunostaining).
For chimera production, the !-gal+ selected clones were further expanded in ES culture medium (ES derivation medium without 2i) on MEFs. C57BL/6N females were superovulated and mated with C57BL/6N males. At E3.5, blastocyts were collected, injected with wildtype (control) or homozygous Isl1-null;nlacZ ES cells (2-6 cells/blastocyst) and were subsequently transfered into the uterus of 0.5 or 2.5 dpc pseudopregnant B6CBAF1 females (15-17 blastocyts/females). Chimeric fetuses were harvested at E16.5 or E18.5 for analysis. The collected fetuses were dissected in PBS at 4°C to remove the caudal part below the stomach, then fixed 3h at 4°C in 4% paraformaldehyde (PFA, Electron Microscopy Sciences, 15710), 0.5% Triton X-100 (SIGMA, T8787) and extensively washed in PBS with 0.1% Tween 20 (PBST) (SIGMA, P1379). To evaluate the contribution of ES cells to specimens, X-gal staining was performed on the dissected lower part of the fetuses. The analysis was performed by immunofluorescent stainings on cryosections of the rostral part of the fetuses.
Generation of Tbx1-null chimeras
The Isl1 nuclear LacZ (nLacZ) knock-in mouse 129/SV ES line (Isl1 lacZ ) was obtained from Sylvia Evans (Sun et al., 2007) . ES cells were cultured on MytomycinC treated embryonic primary fibroblasts onto gelatin coated dishes in DMEM-KO media (Gibco, 10829-018) containing 15% FBS (Biowest), 0,5% penicillin/streptomycin (Gibco, 15140, stock100x), 0.1% !-mercaptoethanol (SIGMA, M7522, stock 100mM in PBS), 1% L-Glutamine (Gibco, 25030024, stock 200mM) and 1000U/ml ESGRO® recombinant mice leukemia inhibitory factor (LIF, Millipore, ESG1107, stock 10 7 U/ml).
For ES cell injection and chimera production, 4 week old Tbx1 +/females were superovulated and mated with Tbx1 +/males (on a mixed genetic background C57BL/6JRj and DBA/2JRj, Janvier Labs). At E3.5, blastocyts were collected, injected with Isl1 lacZ ES cells (6-12 cells/blastocyst) and were subsequently transfered into uteri of 0.5 or 2.5 dpc pseudopregnant B6CBAF1 females.
Chimeric fetuses were harvested at E14.5/E15.5 for analysis. The collected fetuses fixed 2h30 at 4°C in 4% paraformaldehyde 0.2% Triton X-100 and extensively washed in PBS at 4°C. For genotyping of the chimeric embryos, the visceral yolk sac layers were separated using the trypsin/pancreating method as described in ( For the analysis of lacZ+ chimeric embryos, the digestive tract including the pharynx, trachea, esophagus, heart, stomach and diaphragm was further dissected and X-Gal stained overnight at 37°C or embryos were processed for cryosections and immunostaining on sucrose/OCT as described above.
Methods details
X-Gal staining and Immunofluorescense
Wholemount samples were analysed for !-galactosidase activity with 400 µg/ml X-Gal (SIGMA 15520-018; Stock solution 40mg/ml in DMSO) in PBS buffer containing 4 mM potassium ferricyanide, 4 mM potassium ferrocyanide, 0.02% NP-40 and 2 mM MgCl2 as previously described .
For immunostaining on cryosections, embryos and fetuses were fixed 3h in 4% PFA and 0,2-0,5% Triton X-100 at 4°C, washed overnight at 4°C in PBS, cryopreserved in 30% sucrose in PBS and embedded in OCT for cryosectioning. Cryosections (16-18µm) were allowed to dry for 30 min and washed in PBS. For immunostaining on paraffin sections, samples were fixed overnight in 4% PFA, dehydrated in graded ethanol series and penetrated with Histoclear II (HS-202, National Diagnostics) and embedded in paraffin. Paraffin blocks were sectioned at 12 µm using a Leica microtome. Sections were then deparaffinized and rehydrated by successive immersions in Histoclear, ethanol and PBS series. When needed, samples were then subjected to antigen retrieval with 10 mM Citrate buffer (pH 6.0) using a 2100 Retriever (Aptum Biologics).
Rehydrated sections were blocked for 1h in 10% normal goat serum, 3% BSA, 0.5% Triton X-! 18! 100 in PBS. Primary antibodies were diluted in blocking solution and incubated overnight at 4°C. After 3 rounds of 15 min washes in PBST, secondary antibodies were incubated in blocking solution 1h at RT together with 1µg/ml Hoechst 33342 to visualize nuclei. Antibodies used in the study are listed in Table1. After 3 rounds of 15 min washes in PBST, slides were mounted in 70% glycerol in PBS for analysis. For Edu staining, immunostaining for primary and secondary antibodies was performed first, followed by the click chemical reaction using Alexa633 as a reactive fluorophore for EdU detection (Life Technologies C10350).
For whole mount immunostaining, embryos were fixed and washed as above. Esophagi were micro-dissected in PBST and incubated in blocking buffer (10% goat serum, 10% BSA, 0.5% TritonX-100 in 1X PBS) for 1h at RT in 2ml Eppendorff tubes. The tissue was then incubated with primary antibodies in the blocking buffer for 4-5 days at 4°C with rocking. The tissue was washed extensively for 2h-4h in PBST and then incubated in Fab' secondary antibodies for 2 days at 4°C with rocking. The tissue was washed as above, dehydrated in 50% Methanol in PBS, 100% Methanol and then cleared with BABB and mounted for imaging as in (Yokomizo et al., 2012) .
Rnascope® in situ hybridization
E14.5 embryos were collected, fixed overnight in 4% PFA, washed in PBS 3x15min, equilibrated in 15% and 30% sucrose and embedded in OCT. Tissue blocks were stored at -80C. 18µm thick cryosections were collected on Superfrost Plus slides and stored at -80 till use (less than 2 months).
RNAscope® probes Mm-Hgf (315631) and Mm-Met (405301) were designed commercially by the manufacturer and are available from Advanced Cell Diagnostics, Inc. In situ hybridization was performed using the RNAscope® 2.5 HD Reagent Kit-Red according to manufacturer's instructions (Wang et al., 2012) with modifications. For sample pre-treatments: H2O2 treatment was 10min at RT, retrival was done for 2 min at 98°C and slides were digested with Protease Plus reagent for 15min at 40°C. The AMP1 to AMP6 steps were done as in the standard protocol. Before detection, samples were washed in PBS 3x 5min and immunostaining performed as above with fluorescent secondary antibodies. Sections were then washed in Rnascope® Wash buffer, detection done with Fast-Red A/B mix and slides mounted in . As the Fast-Red chromogenic precipitate is also visible by fluorescence microscopy using the 555nm laser, sections were imaged using a 40x objective on a LSM700 microscope (Zeiss). For quantitation of Met RNAscope® staining, the ! 19! number of individual signal dots or clusters per mGFP+ cell was counted manually on Fiji.
Cells were attributed the score 1 (1 to 3 dots/cell), 2 (4 to 9 dots/cell) or 3 (more than 10 dots/cells or big clusters) and correlated to the presence or absence of Myod/Myog nuclear staining.
Enzymatic digestion for cell sorting
The masseter muscles and esophagi from Tg:Pax7nGFP timed embryos were dissected in cold PBS and kept in cold GlutaMAX/DMEM (Gibco, 31966) with 1% Penicillin-Streptomycin. and StepOne-Plus Real Time PCR System (Applied Biosystems). TBP transcript levels were used for normalizations of each target (2"CT). At least three biological replicates and technical duplicates were used for each condition method (Schmittgen et al., 2008) . For SYBR-Green, custom primers were designed using the Primer3Plus online software. Serial dilutions of total cDNA were used to calculate the amplification efficiency of each primer set according to the equation: E=10 -1/slope. Primer sequences used are detailed in Table1.
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Single-cell qPCR analysis
Gene expression in single cells was analysed using the Fluidigm Gene Expression Assay (BioMark). Briefly, oesophagus was dissected and digested with trypsin/collagenase to obtain a single cell suspension as described above. Single cells and bulk control (20 cells/well) were sorted directly on a FACS Aria III in 9 µl of Specific Target Amplification (STA) reaction mix from the CellsDirect One-Step qRT-PCR kit (Invitrogen) containing 0.2XTaqMan Gene Expression Assay mix. Pre-amplified cDNA (18 cycles) was obtained according to manufacturer's note and was diluted 1:5 in TE buffer for qPCR. Multiplex qPCR was performed using the microfluidics Biomark system on a Biomark HD for 40 cycles. The same TaqMan probes were used for both RT/STA and qPCR. TaqMan assays used in the study are listed in Table 2 .
Convertion to relative expression
Raw Ct values were converted in relative expression using the following formula : Log2ex = LOD -Ct[Array] (Livak et al., 2013) . With the LOD standing for the Limit Of Detection. When the Log2ex value obtained was negative (Ct[array]>LOD) the value was replaced by 0. To set up the LOD, we round the mean of the maximum Ct values for all the genes to the upper limit which gives a LOD of 21.
Normalization
The resulting relative expression values were normalized to the endogenous controls by substracting, for each cell, the average of its Actb, Rpl13, Rps29, and Hprt expression levels.
An offset corresponding to the mean of all the calculated means was applied to all obtained values to avoid negative values.
Single cell filtering
From two independent experiments 66 cells were collected from the esophage. The criteria to keep a cell for further analysis were the following : i) to discard neurogenic progenitors, cells should not express Pax3 and/or Lhx3. ii) at least 4 out of the 5 positive control genes should be expressed, as well as at least 2 of the genes of interest. Applying this different filters 23 single cells were selected.
Correlation coefficient determination and p-value calculation
The Spearman's rho correlation coefficient was calculated using the R function cor() with the 'use' parameter set at « pairwise.complete.obs », and all the null values previously replaced by NAs.
The coefficient correlation p-value was extracted from the cor.test() R function, using the same parameters.
! 21!
Data visualisation
The heatmap ( Fig S5B) was generated using the pheatmap R package (pheatmap_1.0.10) with default parameters, and the correlogram ( Fig 5F) was generated using the corrplot R package(corrplot_0.84), with the p-values mannually added. Violin plots in figure S1 were made in R using the ggplot2 package (ggplot2_3.1.0). R session info: R version 3.5.1 (2018-07-02), platform: x86_64-apple-darwin15.6.0 (64-bit), running under: macOS Sierra 10.12.6
Static Imaging
Images were acquired using the following systems: Zeiss SteREO Discovery V20 microscope for whole embryos, a Zeiss Axioplan equipped with an Apotome and ZEN software (Carl Zeiss), Leica SPE or Leica TCS-SP8 with Leica Application Suite (LAS) software for tissue sections and a LSM 700 laser-scanning confocal microscope and ZEN software (Carl Zeiss) for tissue sections and whole mount immunostaining of cleared embryos. All images were assembled in Adobe Photoshop and InDesign (Adobe Systems). Volume-3D rendering on the z-stack series was performed in Imaris (version 7.2.1) software (Bitplane).
Explant culture
Esophagi from E14.5 Isl1 Cre/+ :R26 mTmG/+ embryos were micro-dissected leaving the stomach and pharyngeal muscles attached in RT HBSS (Gibco, 14025) . The esophagi were immobilized on individual wells of 8 well glass bottom dishes (Ibidi, 80826) at the stomach end and pharyngeal ends using 0.3µl of Vetbond tissue adhesive (3M TM , 1469SB). The explants were immediately embedded in a collagen matrix as previously reported (Placzek and Dale, 1999) with slight modifications. 700µl of collagenI (Corning, 354236) For time-lapse imaging, the dish was placed in a microscope incubator chamber (37°C, 5% CO2) and the mGFP signal imaged with the 488 laser on an Leica TCS-SP8 inverted microscope, equipped with a HC PL APO CS2 10X/0.40 Dry objective and HyD hybrid detector (496-566nm). Confocal imaging of optical Z-planes (2.41µm) were acquired every 15 minutes over 14h using LAS X software. Z-stacks were projected as maximum intensity projection images, stitched and registered (linear registration) in Fiji. The migrating cells were tracked individually frame-by-frame using the 'Manual Tracking' plugin in Fiji. The following parameters were quantitated: total distance (µm, the distance covered by the whole track), velocity (µm/min, ratio between the total distance and total time of the track), displacement (µm, the lenght of the resultant vector between ti and tf of the track), efficiency (ratio between displacement and total distance), net velocity (µm/min, ratio between the displacement and total time of the track).
Quantitation of muscle area
The muscle area on transverse esophagus cryosections (Suppl. Figure 1I ) was quantified on Fiji. Channels were split threshold levels adjusted on the Tnnt3 channel. The freehand selection tool was used to trace the outline of each esophagus crossection (referred as Region of interest, ROI). Threshold levels were kept constant for all samples. The Analyze/Measure tool was set to calculate the area of the ROI limited to the threshold for the Tnnt3 channel.
EdU Administration In Vivo
For proliferation experiments in vivo, 5-ethyl-20-deoxyuridine (EdU; Invitrogen E10187) was injected intraperitoneally and detected as described in . (C-E) Immunostainings on coronal cryosections of a E18.5 Isl1 Cre ;R26 mTmG mouse for the GFP reporter, Myod/Myog/Tnnt3 (myogenic markers) and SMA (smooth muscle actin) in the esophagus and tongue. Note that Isl1-derivatives include the esophagus striated muscle but not the esophagus smooth muscle layers and tongue muscle (n=2). (F) Correlogram. The upper part of the mixed correlogram displays graphically the degree of relationship between genes with the bigger the circle, the higher the Spearman's correlation coefficient, the redder, the more negative, the bluer, the more positive. CPM, cardiopharyngeal mesoderm; bc, buccinator; e, esophagus; esm, esophagus striated muscles; lgm, laryngeal muscles; ms, masseter; oo, orbicularis oculi; PA1-6, pharyngeal arches 1-6; pc, pharyngeal constrictor; pl, platysma; st, stomach; te, temporal; tpm, trapezius muscles. 
